Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfeffer

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
American Heart Journal|February 15, 2001
Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysisY Aikawa, L Rohde, J Plehn, et al.
Kardiologiia|January 1, 1993
[Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies]M A Pfeffer, Iu Braunvald, L A Moĭe, et al.
Lancet (London, England)|September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trialJ L Rouleau, M A Pfeffer, D J Stewart, et al.
Circulation Research|May 1, 1984
Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the ratK F Badr, C Baylis, J M Pfeffer, et al.
Journal of the American College of Cardiology|July 10, 1999
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE InvestigatorsG C Flaker, J W Warnica, F M Sacks, et al.
The New England Journal of Medicine|March 18, 1993
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigatorsJ L Rouleau, L A Moyé, M A Pfeffer, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
Circulation|January 1, 1994
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captoprilM St John Sutton, M A Pfeffer, T Plappert, et al.
The New England Journal of Medicine|September 13, 1992
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsM A Pfeffer, E Braunwald, L A Moyé, et al.
JAMA|July 24, 1991
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE InvestigatorsM A Pfeffer, L A Moyé, E Braunwald, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
American Heart Journal|February 15, 2001
Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysisY Aikawa, L Rohde, J Plehn, et al.
Kardiologiia|January 1, 1993
[Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies]M A Pfeffer, Iu Braunvald, L A Moĭe, et al.
Lancet (London, England)|September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trialJ L Rouleau, M A Pfeffer, D J Stewart, et al.
Circulation Research|May 1, 1984
Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the ratK F Badr, C Baylis, J M Pfeffer, et al.
Journal of the American College of Cardiology|July 10, 1999
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE InvestigatorsG C Flaker, J W Warnica, F M Sacks, et al.
The New England Journal of Medicine|March 18, 1993
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigatorsJ L Rouleau, L A Moyé, M A Pfeffer, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
Circulation|January 1, 1994
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captoprilM St John Sutton, M A Pfeffer, T Plappert, et al.
The New England Journal of Medicine|September 13, 1992
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsM A Pfeffer, E Braunwald, L A Moyé, et al.
JAMA|July 24, 1991
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE InvestigatorsM A Pfeffer, L A Moyé, E Braunwald, et al.
Pageof 19